{"id":"25011bdec80d","type":"article","url":"https://hartvaat.nl/2021/07/01/kbp-5074-en-bloeddruk-bij-gevorderde-ckd-block-ckd/","title":"KBP-5074 en bloeddruk bij gevorderde CKD: BLOCK-CKD","title_en":"Effect of KBP-5074 on Blood Pressure in Advanced Chronic Kidney Disease: Results of the BLOCK-CKD Study.","category":"hypertensie","category_label":"Hypertensie","professions":["cardioloog","internist"],"tags":["chronische-nierziekte"],"journal":"Hypertension (Dallas, Tex. : 1979)","doi":"10.1161/HYPERTENSIONAHA.121.17073","source_url":"https://doi.org/10.1161/HYPERTENSIONAHA.121.17073","authors":["George Bakris","Pablo E Pergola","Belkis Delgado","Diyan Genov","Tamar Doliashvili","Nam Vo","Y Fred Yang","James McCabe","Vincent Benn","Bertram Pitt"],"significance":6,"published":"2021-07-01","source_date":"2021-07-01","image":"","kennis":["https://hartvaat.nl/kennis/hypertensie/hypertensie-en-ckd/"],"congress":"","summary_en":"The BLOCK-CKD study evaluated KBP-5074, a nonsteroidal MRA, for blood pressure lowering in advanced CKD, testing a novel mineralocorticoid receptor antagonist designed for safety in the renally impaired population.","created":"2026-07-03T10:29:15Z","updated":"2026-07-03T13:28:23Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"BLOCK-CKD studie naar KBP-5074 (niet-steroïdale MRA) op bloeddruk bij gevorderde CKD.","abstract_original":"[Figure: see text]."}